Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 110 participants.
Also called NCT05711849
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 110 participants
- Sponsor
- Registry
-
NCT05711849
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT05711849. Randomized; double masking; primary purpose treatment. Start 2024-03-01 (actual); primary completion 2026-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina
- Acronym
- RegenCobra
- Condition
- Refractory Angina Pectoris
- Condition
- Refractory Angina
- Intervention (Biological)
- Bone marrow aspiration and a single intracoronary infusion of autologous bone marrow-derived mononuclear cells.
- Intervention (Procedure)
- Sham bone marrow aspiration and sham cell infusion (insertion of vascular access sheath).
- Lead sponsor
- Barts & The London NHS Trust
Record details
- Record id
cardio:ct-nct05711849- Content hash
78caefd7ef01fcc9af29856cd138861b90f0c247ef2dc72df31445384f8a5578